GE HealthCare Technologies Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of GE HealthCare Technologies Inc. (NASDAQ: GEHC). The investigation focuses on GE HealthCare’s executive officers and whether investor losses may be recovered under federal securities laws.
What if I purchased GE HealthCare securities?
If you purchased GE HealthCare securities and suffered losses on your investment, join our investigation now: Click here to join the investigation.
Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471.
There is no cost or obligation to you.
Background of the investigation
On April 29, 2026, GE HealthCare reported its first quarter 2026 financial results. Among other things, the Company disclosed diluted earnings per share of $0.85, compared to $1.23 in the prior-year period, and adjusted earnings per share of $0.99, compared to $1.01 in the prior-year period.
GE HealthCare also reduced its full-year 2026 adjusted earnings per share guidance to a range of $4.80 to $5.00, down from prior guidance of $4.95 to $5.15, and lowered its adjusted EBIT margin guidance. The Company stated that the inflation landscape changed significantly during the first quarter, increasing expected input costs by approximately $250 million in 2026. GE HealthCare further disclosed that it expected to offset only a portion of these cost pressures through pricing and cost actions.
In addition, GE HealthCare disclosed that the expected benefit from pricing actions would be more heavily weighted toward the second half of the year because many sales were already in backlog, limiting the Company’s ability to offset rising costs in the near term.
Following this disclosure, GE HealthCare’s stock price declined sharply, damaging investors.
In light of this disclosure, Johnson Fistel is investigating whether GE HealthCare complied with the federal securities laws. If you suffered losses from your investment in GE HealthCare stock, contact Johnson Fistel.
About Johnson Fistel, PLLP | Securities Fraud & Investor Rights
Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits and also assists foreign investors who purchased shares on U.S. exchanges. To learn more, visit www.johnsonfistel.com.
Achievements
In 2024, Johnson Fistel was ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services, reflecting the firm’s effectiveness in advocating for investors and recovering approximately $90,725,000 for clients in cases where it served as lead or co-lead counsel.
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.
Contact
Johnson Fistel, PLLP
501 W. Broadway, Suite 800
San Diego, CA 92101
James Baker, Investor Relations – or – Frank J. Johnson, Esq.
(619) 814-4471 | jimb@johnsonfistel.com | fjohnson@johnsonfistel.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
